If you've ordered a Precision Epigenomics EPISEEK early cancer detection test, congratulations! You've been proactive about cancer screening. What happens next? This helpful video walks you through how the test is received by the lab, how the lab processes your liquid biopsy, what cancers the test looks for, the accuracy level of the test, and what your results actually mean. Watch now to learn more: https://lnkd.in/gSyGfv5z #PrecisionEpigenomics #EarlyCancerDetection #EPISEEK #CancerAwareness #CancerTest
Precision Epigenomics
Medical and Diagnostic Laboratories
Tucson, Arizona 278 followers
Advanced Solutions to Early Cancer Diagnostics
About us
- Website
-
https://precision-epigenomics.com/
External link for Precision Epigenomics
- Industry
- Medical and Diagnostic Laboratories
- Company size
- 2-10 employees
- Headquarters
- Tucson, Arizona
- Type
- Privately Held
Locations
-
Primary
Get directions
630 N Alvernon Way
STE 280B
Tucson, Arizona 85711, US
Employees at Precision Epigenomics
Updates
-
Arizona Commerce Authority, Grateful to the crew and judges to have studied 130 applicants from #azstartups trying to make our marks. Precision Epigenomics team is honored to be selected as a semifinalist. Eager to see the feedback and looking forward to November 20th to share our #EPISEEK #earlydetection test with peers and judges. ¡Congratulations to all Semifinalists and all AZ folks living the #startuplife! #cancerawareness #earlycancerdetection #earlydetection #pink #cancerresearch #thinkpink
Congratulations to the 2024 Arizona Innovation Challenge Semifinalists! 💡👏 MORE ➡️ https://lnkd.in/gWqgSs9t
-
Early cancer detection saves lives! To learn more about Precision Epigenomics from our founder and CEO, Dr. Mark Nelson, watch this video: https://lnkd.in/g6g4iucF #PrecisionEpigenomics #EarlyCancerDetection #CancerAwareness #CancerTest
Dr. Mark Nelson on Precision Epigenomics and Early Cancer Detection
https://www.youtube.com/
-
Step into the future of healthcare with Precision Epigenomics! Our unique early-detection test is the only multi-cancer test on the market capable of identifying brain cancer. Trust Precision Epigenomics to advance your practice and improve patient peace of mind! Click here to order tests today: https://lnkd.in/eQEdBr7m #EarlyDetection #CancerAwareness #PrecisionEpigenomics
-
-
Wanna know more about the Epigenome and #cancer? Check out this Podcast from our own Joshua Routh and good friend Hannah Went from Everything Epigenetics. Great conversation.
Season 2, Episode 10 - Detecting the Undetectable: Epigenetics in Early Cancer Detection with Joshua Routh Check out the links in the comments! Recent research from the University of Chicago shows that only 14% of cancers in the U.S. are diagnosed after the patient had a recommended screening test. 57% of diagnosed cancers do not have screening tests and account for 70% of all cancer-related deaths. 86% of cancer cases still go undiagnosed after recommended screenings. 16M life years saved in the U.S. from early-detection screenings. I don't know about you, but everytime I read those stats, my jaw hits the floor. When it comes to cancer, early detection is key to saving lives. With 610,000 cancer deaths in the U.S. each year, most of which stemming from cancer types with no FDA-approved screening options, new technology is making revolutionary strides in detecting cancers that have been previously undetectable in early stages. There are now new tools intended to be used complementary to established cancer screening assessments. However in some cases, especially for cancer types that have no previously established screening test and are notoriously hard to detect, it may be the only warning sign currently available for providers. In this week’s episode of the Everything Epigenetics podcast, Dr. Joshua Routh and I talk about just that. We discuss the rising cancer burden and the cutting-edge role epigenetics plays in revolutionizing early cancer detection. Dr. Routh, a molecular genetic pathologist and medical director at Precision Epigenomics, shares insights into how new diagnostics, such as Multi-Cancer Detection (MCD) tests, provide opportunities to catch cancers earlier than ever before. We also explore the technology behind these tests, their impact on patient outcomes, and what the future holds for epigenetics in diagnosing and treating cancer and other chronic diseases. You'll learn about: - Dr. Joshua Routh’s journey from engineering to molecular oncology. - The alarming statistics behind late-stage cancer diagnoses and why early detection is critical. - Current cancer screening limitations and how epigenomics offers better solutions. - How Multi-Cancer Detection (MCD) tests like EPISEEK work to catch cancer earlier. - The difference between EPISEEK by Precision Epigenomics and Galleri by Grail. - Why test accuracy matters - What to expect if you get a positive cancer result and how recurrence monitoring works. - The broader future of epigenetics in treating conditions like heart disease and neurological disorders. #everythingepigenetics
-
-
Introducing the EPISEEK™ early cancer detection kit! Designed and offered by Precision Epigenomics, this liquid biopsy test is a blood-based test designed to accurately assess the presence of tumors through cell-free DNA analysis. This technology is cost-effective, precise, minimally invasive, and may detect cancer earlier than imaging. Watch this kit unboxing video to see what's included! Order your tests today at: https://lnkd.in/eQEdBr7m #EPISEEK #EarlyCancerDetection #CancerAwareness #PrecisionEpigenomics
-
It’s another great day at #AZBW 2024 with Arizona BioIndustry Association (AZBio) White Hat Extravaganza. Kiran Avancha, PhD Jamaine Aggrey Jason Jardine Joan Koerber-Walker giving straight talk on what startups need to understand about hospitals as investors.
-
-
Discover EPISEEK™, our revolutionary liquid biopsy test that detects all major cancer types, including brain, prostate, breast, pancreas, and more. With just a simple blood draw, EPISEEK™ provides vital insights into the presence of tumors through cell-free DNA analysis. Our cost-effective and precise technology identifies cancer-specific DNA methylation, ensuring early detection and greater accessibility compared to traditional biopsies. Watch this video to learn more: https://lnkd.in/gtqR9nTa #EPISEEK #EarlyDetection #CancerAwareness #LiquidBiopsy #HealthInnovation #PrecisionEpigenomics
-
-
Early detection of cancer can be make all the difference in treatment. Delayed cancer detection lowers survival rates significantly. When detected early, the five-year survival rate for many cancers can be over 90%. This percentage decreases the longer the cancer goes undetected. Detecting cancer before symptoms appear gives patients the best chance for successful treatment and recovery. Get in front of cancer with Precision Epigenomics. Talk to your doctor about the EPISEEK™ early cancer detection test! Learn more at https://lnkd.in/gX5jXBjp. #EarlyDetection #CancerAwareness #HealthcareAdvanced #PrecisionEpigenomics #EPISEEK
-
-
We are grateful to the thoughtful, generous, and caring investors who see the power of earlier detection and who believe in our mission and team.
COO of Precision Epigenomics & VP of Dermatopathology Client Relations at Sonic Healthcare USA
More good news for Team Precision Epigenomics and #episeek - our #multicancer detection test. These early investors stood up our CLIA lab, validated the EPISEEK assay for commercial use, and support ongoing R&D for cancer patients. #cancerawareness #cancer #screeningsaveslives